The tumor volume and tumor weight in the deguelin-treated Mcl-1 5KR mutant group were significantly larger than that of the deguelin-treated Mcl-1 WT group (Supplementary Fig. 4, a, c). This evidence concerns the gene MCL1 and neoplasm.